X0708 D LIVE 0001401040 DiaMedica Therapeutics Inc. 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN MINNESOTA 55447 (763) 496-5454 CANADA (FEDERAL LEVEL) None DiaMedica Inc. Corporation true Rick Pauls 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Executive Officer Director Todd Verdoorn 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Executive Officer Scott Kellen 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Executive Officer Paul Papi 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Executive Officer David Gurvey 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Executive Officer Richard Pilnik 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Director Michael Giuffre 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Director James Parsons 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Director Zhenyu (Jerry) Xiao 2 Carlson Parkway, Suite 260 Minneapolis MN MINNESOTA 55447 Director Biotechnology Decline to Disclose 06b false 2018-03-29 true true true true true Unit offering, each unit consisting of one common share and 1/2 common share purchase warrant; each whole warrant may be exercised for one common share at $0.35 for 2 years false 0 344348 200870 143478 (c) represents unexercised warrants issued to U.S. purchasers false 7 0 0 0 false DiaMedica Therapeutics Inc. /s/ Scott Kellen Scott Kellen Chief Financial Officer & Corporate Secretary 2018-04-17